Lucid Diligence Brief - BioPharma

Intravacc and SynphaBase Conjugate Vaccine Partnership | Lucid Diligence Brief

Can Intravacc and SynphaBase create a streamlined synthetic glycan-to-GMP…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: ERS Genomics and Aurigene CRISPR/Cas9 License

Lucid Diligence Brief: ERS Genomics’ CRISPR/Cas9 IP license to Aurigene raises…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Transcenta x EirGenix HiCB licensing

Lucid Diligence Brief: Transcenta x EirGenix HiCB licensing Professional…


Privacy Preference Center